Biophytis S.A. (ALBPS.PA)
EUR 0.18
(-0.22%)
EUR 0.18
(-0.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.33 Million | -18.98 Million | -23.79 Million | -9.86 Million | -15.27 Million | -12.05 Million |
| Net Income | -17.02 Million | -24.21 Million | -31.24 Million | -17.05 Million | -17.78 Million | -13.98 Million |
| Depreciation & Amortization | 803 Thousand | 484 Thousand | 311 Thousand | 280 Thousand | 262 Thousand | 227 Thousand |
| Deferred income taxes | -2.07 Million | - | 1.91 Million | -1.4 Million | -759 Thousand | 108 Thousand |
| Stock-based compensation | 812 Thousand | 5.56 Million | 3.42 Million | 785 Thousand | 63 Thousand | 287 Thousand |
| Change in working capital | -26 Thousand | -1.33 Million | 1.32 Million | 3 Million | -361 Thousand | 1.13 Million |
| Other non-cash items | 4.18 Million | 512 Thousand | 485 Thousand | 4.52 Million | 3.31 Million | 169 Thousand |
| Investing Cash Flow | 370 Thousand | -17 Thousand | 12.16 Million | -12.71 Million | -278 Thousand | -104 Thousand |
| Investments in PPE | -220 Thousand | -141 Thousand | -344 Thousand | -214 Thousand | -282 Thousand | -113 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -12.5 Million | - | - |
| Sales/Maturities of investments | 590 Thousand | 124 Thousand | 12.5 Million | - | - | - |
| Other Investing Activities | 590.00 | 110 Thousand | 4000.00 | 1000.00 | 4000.00 | 9000.00 |
| Financing Cash Flow | 7.48 Million | 6.13 Million | 29.71 Million | 22.07 Million | 7.5 Million | 6.77 Million |
| Debt repayment | -1.38 Million | -2.08 Million | -3.6 Million | -3.96 Million | -47 Thousand | -70 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.38 Million | 6000.00 | 16.58 Million | 23.48 Million | - | -30 Thousand |
| Other Financing Activities | 1000.00 | 8.21 Million | 16.73 Million | 2.55 Million | 7.54 Million | 6.84 Million |
| Accounts receivables | 1.67 Million | -398 Thousand | -1.29 Million | 2.65 Million | -2.94 Million | -1.37 Million |
| Accounts payables | -1.32 Million | -718 Thousand | 380 Thousand | 119 Thousand | 2.64 Million | 2.3 Million |
| Inventory | - | 398 Thousand | 1.29 Million | -2.65 Million | 2.94 Million | - |
| Other working capital | -368 Thousand | -617 Thousand | 940 Thousand | 2.88 Million | -3 Million | -1.16 Million |
| Cash at beginning of period | 11.05 Million | 23.92 Million | 5.84 Million | 6.33 Million | 14.4 Million | 19.85 Million |
| Cash at end of period | 5.56 Million | 11.05 Million | 23.92 Million | 5.84 Million | 6.33 Million | 14.4 Million |
| Capital Expenditure | -220 Thousand | -141 Thousand | -344 Thousand | -214 Thousand | -282 Thousand | -113 Thousand |
| Effect of forex changes on cash | -9000.00 | -3000.00 | -1000.00 | 13 Thousand | -18 Thousand | -61 Thousand |
| Net cash flow / Change in cash | -5.48 Million | -12.87 Million | 18.07 Million | -490 Thousand | -8.06 Million | -5.45 Million |
| Free Cash Flow | -13.55 Million | -19.12 Million | -24.13 Million | -10.07 Million | -15.55 Million | -12.17 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2906.00 | -2906.00 | -4631.00 | -17.02 Million | -4631.00 | -3882.00 |
| Depreciation & Amortization | 74.00 | 74.00 | 364.00 | 803 Thousand | 273.50 | 128.00 |
| Deferred income taxes | - | - | 247.74 Thousand | -2.07 Million | - | -1.51 Million |
| Stock-based compensation | 257.50 | 257.50 | 252.00 | 812 Thousand | 252.00 | 161.00 |
| Change in working capital | 15.50 | 15.50 | -148.50 | -26 Thousand | -148.50 | 1015.50 |
| Other non-cash items | -417.50 | -417.50 | 1808.00 | 4.18 Million | 1898.50 | -1503.50 |
| Investing Cash Flow | -4.50 | -4.50 | 573.50 | 370 Thousand | 573.50 | -388.50 |
| Investments in PPE | -4.50 | -4.50 | -65.00 | -220 Thousand | -65.00 | -45.00 |
| Acquisitions | - | - | -638.50 | - | - | 343.50 |
| Investment purchases | - | - | 695 Thousand | - | - | -695 Thousand |
| Sales/Maturities of investments | - | - | 582 Thousand | 590 Thousand | - | 8000.00 |
| Other Investing Activities | - | - | 638.50 | 590.00 | 638.50 | -343.50 |
| Financing Cash Flow | 1291.00 | 1291.00 | 1669.50 | 7.48 Million | 1669.50 | 1844.00 |
| Debt repayment | - | - | -330 Thousand | -1.38 Million | - | -1.05 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 4.42 Million | 6.38 Million | - | 1.96 Million |
| Other Financing Activities | 1291.00 | 1291.00 | 1669.50 | 1000.00 | 1669.50 | 1844.00 |
| Accounts receivables | 61.00 | 61.00 | -174.00 | 1.67 Million | -174.00 | 1009.00 |
| Accounts payables | - | - | 1.9 Million | -1.32 Million | - | -3.23 Million |
| Inventory | - | - | - | - | - | 1.00 |
| Other working capital | -45.50 | -45.50 | 25.50 | -368 Thousand | 25.50 | 6.50 |
| Cash at beginning of period | - | - | 5.78 Million | 11.05 Million | - | 11.05 Million |
| Cash at end of period | -1690.00 | -1690.00 | 5.56 Million | 5.56 Million | -105.00 | 5.78 Million |
| Capital Expenditure | -4.50 | -4.50 | -65.00 | -220 Thousand | -65.00 | -45.00 |
| Effect of forex changes on cash | - | - | 7.50 | -9000.00 | 7.50 | -12.00 |
| Net cash flow / Change in cash | -1690.00 | -1690.00 | -215 Thousand | -5.48 Million | -105.00 | -5.27 Million |
| Free Cash Flow | -2981.00 | -2981.00 | -2420.50 | -13.55 Million | -2420.50 | -4126.00 |
DAL
8AZ
0554
APLUF
RHE
2942